Induction of apoptosis and down-regulation of bcl-6 in Mutu I cells treated with ethanolic extracts of the Chinese herbal supplement PC-SPES

International Journal of Oncology

Volumn 13, Issue 6, 1998, Pages 1199-1202

  Hsieh, Tze Chen ^a   Ng, Chunyung ^a   Chang, Chih Chao ^c   Chen, Sophie S ^a   Mittleman, Abraham ^b   Wu, Joseph M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Zalmen A Arlin Cancer Institute   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Apoptosis; Bcl 6; Immune function; Mutu I cells; PC SPES

Indexed keywords

ONCOPROTEIN; PC SPES; PROTEIN BCL 6; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CHINESE HERB; CONTROLLED STUDY; DIET SUPPLEMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTO ONCOGENE; T LYMPHOCYTE; TERMINAL DISEASE; TUMOR SUPPRESSOR GENE;

EID: 0031773115     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.6.1199     Document Type: Article

References (24)

1. Hsieh TC, Chen SS, Wang X and Wu JM: Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES. Biochem Mol Biol Int 42: 535-544, 1997.
2. Halicka HD, Ardelt B, Juan G, Mittleman A, Chen S, Traganos F and Darzynkiewicz Z: Apoptosis and cell cycle effects induced by extracts of the Chinese herbal preparation PC-SPES. Int J Oncoll 11: 437-448, 1997.
3. Hong WK and Sporn MB: Recent advances in chemoprevention of cancer. Science 278: 1073-1077, 1997.
4. Greco WR, Faessel H and Levasseur L: The search for cytotoxic synergy between anticancer agents: a case of Dorothy and the Ruby Slippers? J Natl Cancer Inst 88: 699-700, 1996.
5. Kawamata N, Miki T, Fukuda T, Hirosawa S and Aoki N: The organization of the bcl-6 gene. Leukemia 8: 1327-1330, 1994.
6. Deweindt C, Albagli O, Bernardin F, Dhordain P, Quief S, Lantoine D, Kerckaert JP and Le Prince D: The LAZ3/bcl-6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. Cell Growth Differ 6: 1495-1503, 1995.
7. Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, Falini B, Louie DC, Offit K, Chaganti RSK and Dalla-Favera R: Bcl-6 proteins is expressed in germinal-center B cells. Blood 86: 45-53, 1995.
8. Fukuda T, Yoshida T, Okada S, Hatano M, Miki T, Ishibashi K, Okabe S, Koseki H, Hirosawa S, Taniguchi M, Miyasaka N and Tokuhisa T: Disruption of the bcl-6 gene results in an impaired germinal center formation. J Exp Med 186: 439-448, 1997.
9. Chang CC, Ye BH, Chaganti RSK and Dalla-Favera R: Bcl-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc Natl Acacl Sci USA 93: 6947-6952, 1996.
10. Ohno H and Fukuhara S: Significance of rearrangement of the bcl-6 gene in B-cell lymphoid neoplasms. Leuk Lymphoma 27: 53-63, 1997.
11. Ohshima A, Miura I, Hashimoto K, Takahashi N, Utsumi S, Nimura T, Saito M, Miki T, Hirosawa S and Miura AB: Rearrangement of the bcl-6 gene and chromosome aberrations affecting 3q27 in 54 patients with non-Hodgkin's lymphoma. Leuk Lymphoma 27: 329-334, 1997.
12. Dierlamm J, Pittaluga S, Stul M, Wlodarska I, Michaux L, Thomas J, Verhoef G, Verhest A, Depandieu C, Cassiman JJ, Hagemeijer A, De Wolf PC and van der Berghe H: bcl-6 gene rearrangements also occur in marginal zone B-cell lymphoma. Br J Hematol 98: 719-725, 1997.
13. Liang R, Chan WP, Kwong YL, Chan AC, Zu WS, Au WY, Srivastava G and Ho FC: bcl-6 gene hypermutations in diffuse large B-cell lymphoma of primary gastric origin. Br J Hematol 99: 668-670, 1997.
14. Bernardin F, Collyn DM, Quief S, Bastard C, Leprince D and Kerckaert JP: Small deletions occur in highly conserved regions of the LAZ 3lbcl-6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation. Oncogene 14: 849-855, 1997.
15. Shen HM, Peters A, Baron B, Zhu X and Storb U: Mutation of bcl-6 gene in normal B cells by the process of somatic hyper-mutation of Ig genes. Science 280: 1750-1752, 1998.
16. Yoshida T, Fukuda T, Okabe S, Hatano M, Miki T, Hirosawa S, Miyasaka N, Isano K and Tokushisa T: The bcl-6 gene is predominantly expressed in keratinocytes at their termination differentiation stage. Biochem Biophys Res Commun 228: 216-220, 1996.
17. Bajalica LS, Piehl F, Farnedo F, Larson C and Lagercrantz J: Expression of the bcl-6 gene in the pre- and postnatal mouse. Biochem Biophys Res Commun 247: 357-360, 1998.
18. Allman D, Jain A, Dent A, Maile RR, Selvaggi T, Kehry MR and Staudt LM: bcl-6 expression during B-cell activation. Blood 87: 5257-5268, 1996.
19. Gregory CD, Rowe M and Rickinson AB: Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J Gen Virol 71: 1481-1495, 1990.
20. 3 in androgen-dependent LNCaP cells. Biochem Biophys Res Commun 235: 539-544, 1997.
21. Hsieh TC, Aguero-Rosenfeld ME, Wu JM, Ng C, Papanikolaou NA, Varde SA, Schwartz I, Pizzolo JG, Melamed M, Horowitz HW, Nadelman RB and Wormser GP: Cellular changes and induction of apoptosis in human promyelocytic HL-60 cells infected with the agent of human granulocytic ehrlichiosis (HGE). Biochem Biophys Res Commun 232: 298-303, 1997.
22. 3 on cellular proliferation, induction of 2′,5′-oligoadenylate (2-5A) synthetase and changes in immunoreactive pRB/p53 in human prostatic JCA-1 cells. Biochem Mol Biol Int 39: 1085-1092, 1996.
23. Oya M, Konno S, Chen Y, Tazaki H, Mallouh C and Wu JM: Control of cell cycle regulatory proteins and modulation of STAT1 proteins by IFN-γ in human prostatic JCA-1 cells. Int J Oncol 10: 835-839, 1997.
24. 1/S transition and induction of apoptosis in HL-60 leukemia cells by fenretinide (4HPR). Int J Cancer 78: 53-61, 1998.